These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 33402227)

  • 1. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
    Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
    Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-β pathology progression in mice.
    Hemonnot-Girard AL; Meersseman C; Pastore M; Garcia V; Linck N; Rey C; Chebbi A; Jeanneteau F; Ginsberg SD; Lachuer J; Reynes C; Rassendren F; Hirbec H
    J Neuroinflammation; 2022 Sep; 19(1):234. PubMed ID: 36153535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
    Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
    Front Immunol; 2021; 12():628156. PubMed ID: 34046031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model.
    Chiu IM; Morimoto ET; Goodarzi H; Liao JT; O'Keeffe S; Phatnani HP; Muratet M; Carroll MC; Levy S; Tavazoie S; Myers RM; Maniatis T
    Cell Rep; 2013 Jul; 4(2):385-401. PubMed ID: 23850290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
    Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
    J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
    Butovsky O; Jedrychowski MP; Cialic R; Krasemann S; Murugaiyan G; Fanek Z; Greco DJ; Wu PM; Doykan CE; Kiner O; Lawson RJ; Frosch MP; Pochet N; Fatimy RE; Krichevsky AM; Gygi SP; Lassmann H; Berry J; Cudkowicz ME; Weiner HL
    Ann Neurol; 2015 Jan; 77(1):75-99. PubMed ID: 25381879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
    Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
    Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial Expression of the Wnt Signaling Modulator
    Aghaizu ND; Jolly S; Samra SK; Kalmar B; Craessaerts K; Greensmith L; Salinas PC; De Strooper B; Whiting PJ
    eNeuro; 2023 Jan; 10(1):. PubMed ID: 36599670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin F (
    Daniels MJD; Lefevre L; Szymkowiak S; Drake A; McCulloch L; Tzioras M; Barrington J; Dando OR; He X; Mohammad M; Sasaguri H; Saito T; Saido TC; Spires-Jones TL; McColl BW
    Elife; 2023 Dec; 12():. PubMed ID: 38085657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease.
    Sobue A; Komine O; Yamanaka K
    Inflamm Regen; 2023 May; 43(1):26. PubMed ID: 37165437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.
    Maeda J; Minamihisamatsu T; Shimojo M; Zhou X; Ono M; Matsuba Y; Ji B; Ishii H; Ogawa M; Akatsu H; Kaneda D; Hashizume Y; Robinson JL; Lee VM; Saito T; Saido TC; Trojanowski JQ; Zhang MR; Suhara T; Higuchi M; Sahara N
    Brain Commun; 2021; 3(1):fcab011. PubMed ID: 33644757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
    Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
    Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.
    D'Ambrosi N; Finocchi P; Apolloni S; Cozzolino M; Ferri A; Padovano V; Pietrini G; Carrì MT; Volonté C
    J Immunol; 2009 Oct; 183(7):4648-56. PubMed ID: 19734218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.
    Takeuchi H; Mizoguchi H; Doi Y; Jin S; Noda M; Liang J; Li H; Zhou Y; Mori R; Yasuoka S; Li E; Parajuli B; Kawanokuchi J; Sonobe Y; Sato J; Yamanaka K; Sobue G; Mizuno T; Suzumura A
    PLoS One; 2011; 6(6):e21108. PubMed ID: 21712989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer's Disease.
    Lau SF; Chen C; Fu WY; Qu JY; Cheung TH; Fu AKY; Ip NY
    Cell Rep; 2020 Apr; 31(3):107530. PubMed ID: 32320664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.